Asia on track for gains, but what's next

Eleanor Creagh

Australian Market Strategist, Saxo

Summary:  A mixed day in Asia as US futures decline, along with the USD.


Another mixed day in Asia, most of the region advancing following the recovery in risk after three consecutive days of gains sustained on Wall Street, whilst Aussie and Kiwi stocks follow US futures lower. ASX200 -4.70%, NZX50 -0.79%, KOSPI +0.47%, Hang Seng +1.21%, Shanghai +1.60%, Nikkei +2.01% at the time of writing. However, the bear market bounce puts the MSCI Asia Pacific index on track for its best week since 2011. The continued pullback in the USD as well as the unprecedented whatever it takes backstop from the Fed, anticipation of the $2trn US fiscal stimulus package and short covering all helping to lift equities off lows.

China today posted the biggest industrial profits fall on record, but the markets focus is elsewhere. The S&P 500 has now retraced 38.2% of its decline from mid-February, but with breadth and volume declining in the Thursday session relative to Wednesday. Whether quarter end rebalancing, stimulus optimism, or just the classic example of a vicious bear market rally following a violent sell-off, as we saw overnight with initial jobless claims all but cementing the path to recession posting in excess of 3mn, the market is in the mood to shrug off the data (for now!). Commodity markets however have not joined the party as copper trades lower along with crude oil. And as we said previously, there is a real disconnect between the real picture which is cascading unemployment, bankruptcy headlines and a true “bottom” in equities.

Meanwhile, the US has now surpassed China in confirmed COVID-19 cases and the immunologist, Dr Anthony Fauci, who serves as a voice of reason the White House Coronavirus task force states, “We are in the escalating phase of a very serious pandemic. That is a fact. We have got to realize that and to prepare and respond. It is not, as it were, under control. Because it's still going up.”

The US is still early on in the infection curve, and the recent rally in risk sentiment is at odds with this outlook. Rightly or wrongly, it is clear by now the markets are not just looking for stimulus measures, monetary and fiscal, to relieve the pressure on risk assets, the more pressing matter is the containment of the virus itself. Markets will not stabilise without the spread of the pandemic slowing with an eye to lockdowns being lifted. Ultimately, we do not yet know the scale of the problem and the task of estimating the depth and duration of the hit to economic growth and earnings is near on impossible at this stage. Even those best placed, the companies themselves have opted to withdraw guidance on earnings. Moreover, the dispersion in analyst and economists’ forecasts for the hit to EPS growth and GDP highlight the level of uncertainty that prevails. We are sceptical of a lasting relief rally until contagion under control, transmission rates reduced and the infection curve flattened. In addition, despite the record setting rally this week, with VIX at 61.00 (a ninth consecutive close above 60, unprecedented!) and VVIX at 169.6 it would be premature to sound the all clear.
Source: 6 figure invest

Shutdowns are becoming more broad-based in Europe and Asia and have the potential to last longer than is currently estimated, the underlying assumption is that shutdowns are lifted and activity bounces back by the 2H and there is no re-infection resulting in another round of shutdowns. Resurgent cases in HK and Singapore and extended containment measures, perhaps indicating that going all in on those assumptions right now is not wise.

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract) and Type 3 Regulated Activity (Leveraged foreign exchange trading) licenses (CE No. AVD061). Registered address: Rooms 2001-02, 20/F York House, The Landmark, 15 Queen's Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.